Frédéric Amant mainly investigates Cancer, Internal medicine, Surgery, Pregnancy and Oncology. His research in Cancer intersects with topics in Molecular biology and Cancer research. His work deals with themes such as Endocrinology, Single-nucleotide polymorphism and Placebo-controlled study, which intersect with Internal medicine.
His Surgery research integrates issues from Neoadjuvant therapy, Debulking and Lymphadenectomy. His Pregnancy study combines topics from a wide range of disciplines, such as Breast cancer, Gynecology and Obstetrics. As a part of the same scientific study, Frédéric Amant usually deals with the Oncology, concentrating on Endometrial cancer and frequently concerns with Carcinoma, Hysterectomy and Predictive value of tests.
Frédéric Amant focuses on Internal medicine, Oncology, Pregnancy, Cancer and Endometrial cancer. Many of his studies involve connections with topics such as Endocrinology and Internal medicine. His Oncology research includes themes of Phases of clinical research, Estrogen receptor, Progesterone receptor and Lymph node, Pathology.
His work focuses on many connections between Pregnancy and other disciplines, such as Obstetrics, that overlap with his field of interest in Cervical cancer. His research brings together the fields of Incidence and Cancer. His Endometrial cancer study incorporates themes from Hysterectomy, Immunohistochemistry, Cancer research, Lymphadenectomy and Serous fluid.
Pregnancy, Cancer, Obstetrics, Internal medicine and Oncology are his primary areas of study. The various areas that he examines in his Pregnancy study include Cohort study, Chemotherapy, Adverse effect, Standard treatment and Pediatrics. His studies deal with areas such as Gestational age and Incidence as well as Cancer.
Frédéric Amant interconnects Developed country, Fertility, Malignancy, Cervical cancer and Small for gestational age in the investigation of issues within Obstetrics. Internal medicine is often connected to Cell-free fetal DNA in his work. Frédéric Amant has researched Oncology in several fields, including Biomarker, Cancer detection, Endometrial cancer and Lymph node.
Frédéric Amant mostly deals with Pregnancy, Cancer, Oncology, Internal medicine and Obstetrics. His Pregnancy research incorporates elements of Chemotherapy, Standard treatment, Fertility preservation, Child development and Pediatrics. His study in Cancer is interdisciplinary in nature, drawing from both Post-pubertal, Gestational age and Infertility.
His work carried out in the field of Oncology brings together such families of science as Biomarker, Hazard ratio, Endometrial cancer and Adenocarcinoma. His Internal medicine study frequently links to other fields, such as Standardized uptake value. His Obstetrics research is multidisciplinary, incorporating perspectives in Vincristine, Diffuse large B-cell lymphoma, Small for gestational age, Hodgkin Lymphoma During Pregnancy and Prednisone.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
Ignace Vergote;Claes G. Tropé;Frédéric Amant;Gunnar B. Kristensen.
The New England Journal of Medicine (2010)
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.
Nicoletta Colombo;Carien Creutzberg;Frederic Amant;Tjalling Bosse.
International Journal of Gynecological Cancer (2016)
Patient-derived xenograft models: an emerging platform for translational cancer research.
Manuel Hidalgo;Frederic Amant;Andrew V. Biankin;Eva Budinská.
Cancer Discovery (2014)
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
Stephen Chia;William Gradishar;Louis Mauriac;Jose Bines.
Journal of Clinical Oncology (2008)
Interrogating open issues in cancer precision medicine with patient-derived xenografts
Annette T. Byrne;Denis G. Alférez;Frédéric Amant;Daniela Annibali.
Nature Reviews Cancer (2017)
Clinical management of uterine sarcomas
Frédéric Amant;An Coosemans;Maria Debiec-Rychter;Dirk Timmerman.
Lancet Oncology (2009)
Cancer During Pregnancy: An Analysis of 215 Patients Emphasizing the Obstetrical and the Neonatal Outcomes
Kristel Van Calsteren;Liesbeth Heyns;Frank De Smet;Liesbet Van Eycken.
Journal of Clinical Oncology (2010)
Tumour hypoxia causes DNA hypermethylation by reducing TET activity
Bernard Thienpont;Jessica Steinbacher;Hui Zhao;Flora D’Anna.
Melanoma addiction to the long non-coding RNA SAMMSON.
Eleonora Leucci;Roberto Vendramin;Marco Spinazzi;Patrick Laurette.
Longitudinal Assessment of Chemotherapy-Induced Structural Changes in Cerebral White Matter and Its Correlation With Impaired Cognitive Functioning
Sabine Deprez;Frederic Amant;Ann Smeets;Ronald Peeters.
Journal of Clinical Oncology (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: